Celera sales and marketing update

Celera disclosed in its 1Q10 earnings that its Berkeley HeartLab Inc. subsidiary launched its 9p21-EarlyMICheck test in the U.S. to detect variants on chromosome 9p21 associated with a risk of cardiov...